Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a consulting agreement with Creative Capital Media (“CCM”). Moving forward, CCM, a media and advertising consultancy, will provide communication and awareness services to InMed in North America.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read More